These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26265968)

  • 21. Supratherapeutic vancomycin levels after trauma predict acute kidney injury and mortality.
    Ley EJ; Liou DZ; Singer MB; Mirocha J; Srour M; Bukur M; Margulies DR; Salim A
    J Surg Res; 2013 Sep; 184(1):501-6. PubMed ID: 23731689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of emergency department delay on outcome in critically ill medical patients: evaluation using hospital mortality and quality of life at 6 months.
    Saukkonen KA; Varpula M; Räsänen P; Roine RP; Voipio-Pulkki LM; Pettilä V
    J Intern Med; 2006 Dec; 260(6):586-91. PubMed ID: 17116010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescribing habits of vancomycin in the Emergency Department: are we dosing appropriately?
    Rosini JM; Grovola MR; Levine BJ; Jasani NB
    J Emerg Med; 2013 May; 44(5):979-84. PubMed ID: 23466019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
    Lawson W; Nathwani D; Eckmann C; Corman S; Stephens J; Solem C; Macahilig C; Li J; Baillon-Plot N; Charbonneau C; Haider S
    Clin Microbiol Infect; 2015 Sep; 21 Suppl 2():S40-6. PubMed ID: 26206621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic Use and Outcomes After Implementation of the Drug Resistance in Pneumonia Score in ED Patients With Community-Onset Pneumonia.
    Webb BJ; Sorensen J; Mecham I; Buckel W; Ooi L; Jephson A; Dean NC
    Chest; 2019 Nov; 156(5):843-851. PubMed ID: 31077649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
    Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of vancomycin minimum inhibitory concentration on mortality among critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia.
    Woods CJ; Chowdhury A; Patel VM; Shorr AF
    Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1246-9. PubMed ID: 23143364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vancomycin Dosing Considerations in a Real-World Cohort of Obese and Extremely Obese Patients.
    Morrill HJ; Caffrey AR; Noh E; LaPlante KL
    Pharmacotherapy; 2015 Sep; 35(9):869-75. PubMed ID: 26343549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Gawronski KM; Goff DA; Brown J; Khadem TM; Bauer KA
    Clin Ther; 2013 Jun; 35(6):772-9. PubMed ID: 23795575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous infusion of vancomycin in methicillin-resistant staphylococcus infection.
    Di Filippo A; De Gaudio AR; Novelli A; Paternostro E; Pelagatti C; Livi P; Novelli GP
    Chemotherapy; 1998; 44(1):63-8. PubMed ID: 9444411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
    Lim HS; Chong YP; Noh YH; Jung JA; Kim YS
    J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
    Eckmann C; Nathwani D; Lawson W; Corman S; Solem C; Stephens J; Macahilig C; Li J; Charbonneau C; Baillon-Plot N; Haider S
    Clin Microbiol Infect; 2015 Sep; 21 Suppl 2():S33-9. PubMed ID: 26198370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.
    Li J; Udy AA; Kirkpatrick CM; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2012 Jan; 39(1):69-72. PubMed ID: 22024354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a pharmacist-to-dose computerized request on promptness of antimicrobial therapy.
    Vincent WR; Martin CA; Winstead PS; Smith KM; Gatz J; Lewis DA
    J Am Med Inform Assoc; 2009; 16(1):47-53. PubMed ID: 18952947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Staphylococcus aureus infections and factors associated with resistance to methicillin in a hospital emergency department.
    González-Castillo J; Cenci C; Rodriguez-Adrada E; Candel FJ; de la Torre-Misiego F; Fernández C; Martín-Sánchez FJ
    Rev Esp Quimioter; 2013 Dec; 26(4):337-45. PubMed ID: 24399347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
    Itani KM; Biswas P; Reisman A; Bhattacharyya H; Baruch AM
    Clin Ther; 2012 Aug; 34(8):1667-73.e1. PubMed ID: 22770644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced Hospital Duration of Stay Associated with Revised Emergency Department-Intensive Care Unit Admission Policy: A before and after Study.
    McCoy JV; Gale AR; Sunderram J; Ohman-Strickland PA; Eisenstein RM
    J Emerg Med; 2015 Dec; 49(6):893-900. PubMed ID: 26409680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort.
    Kullar R; Davis SL; Taylor TN; Kaye KS; Rybak MJ
    Pharmacotherapy; 2012 Mar; 32(3):195-201. PubMed ID: 22392452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High vancomycin minimum inhibitory concentration is associated with poor outcome in patients with methicillin-susceptible Staphylococcus aureus bacteremia regardless of treatment.
    Castón JJ; González-Gasca F; Porras L; Illescas S; Romero MD; Gijón J
    Scand J Infect Dis; 2014 Nov; 46(11):783-6. PubMed ID: 25134647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.